| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |